Bicara Therapeutics (BCAX) vs LB Pharmaceuticals (LBRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
LB Pharmaceuticals (LBRX) has outperformed Bicara Therapeutics (BCAX) over the past year, gaining 113.4% versus a loss of 9.6%. LB Pharmaceuticals is the larger company by market cap ($1.10 billion vs $1.09 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCAX | LBRX |
|---|---|---|
| Share price | $16.42 | $34.16 |
| Market cap | $1.09B | $1.10B |
| 1-day change | -0.85% | -0.29% |
| YTD return | -2.44% | +53.46% |
| 1-year return | -9.63% | +113.37% |
| P/E ratio (TTM) | — | 341.60 |
| EPS (TTM) | $-3.08 | $0.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.99 | $50.16 |
| 52-week low | $13.70 | $14.32 |
| Distance from 52-week high | -47.02% | -31.90% |
| Average volume | 609.70K | 339.93K |
| Shares outstanding | 66.17M | 32.26M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LBRX has outperformed BCAX by 123.0 percentage points over the past year.
BCAX vs LBRX FAQ
Which is bigger, Bicara Therapeutics or LB Pharmaceuticals?
LB Pharmaceuticals (LBRX) is larger, with a market capitalization of $1.10B compared with $1.09B for Bicara Therapeutics (BCAX).
Which stock has performed better over the past year, BCAX or LBRX?
LBRX returned +113.37% over the past 12 months, compared with -9.63% for BCAX (price return, excluding dividends). Past performance does not predict future results.
Are Bicara Therapeutics and LB Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.